
Health Policy
WHO Targets Pediatric Hydroxyurea for Sickle Cell Disease
WHO’s pediatric target product profile could align hydroxyurea development and procurement for children and adolescents with sickle cell disease, but formulation alone will not secure equitable access.
Rayan Salih · September 3, 2026 · 7 min

